The potential roles of 18F-FDG-PET in management of acute stroke patients

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Bunevicius, Adomas ^a   Yuan, Hong ^a   Lin, Weili ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FMZ C 11; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 5; HEXOKINASE; MESSENGER RNA; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; GLUCOSE; DIAGNOSTIC AGENT;

BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN OXYGEN CONSUMPTION; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; DISTRIBUTION VOLUME; DRUG HALF LIFE; DRUG UPTAKE; ENERGY CONSUMPTION; GLUCOSE METABOLISM; HUMAN; LEUKOCYTE MIGRATION; MACROPHAGE MIGRATION; NERVE REGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; REVIEW; STROKE PATIENT; BLOOD; BRAIN CIRCULATION; BRAIN ISCHEMIA; COMPLICATION; DIAGNOSTIC USE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SCINTISCANNING; STROKE;

BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; POSITRON-EMISSION TOMOGRAPHY; STROKE;

EID: 84878732770     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/634598     Document Type: Review

References (112)

1. Go A. S., Mozaffarian D., Roger V. L., Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013 127 1 e6 e245 10.1161/CIR.0b013e31828124ad
2. Donnan G. A., Fisher M., Macleod M., Davis S. M., Stroke. The Lancet 2008 371 9624 1612 1623 2-s2.0-43049135853 10.1016/S0140-6736(08)60694-7 (Pubitemid 351626845)
3. Adams H. P., del Zoppo G., Alberts M. J., Bhatt D. L., Brass L., Furlan A., Grubb R. L., Higashida R. T., Jauch E. C., Kidwell C., Lyden P. D., Morgenstern L. B., Qureshi A. I., Rosenwasser R. H., Scott P. A., Wijdicks E. F., American Heart Association-American Stroke Association Stroke, American Heart A. A. S. A. C. C. C., American Heart Association-American Stroke Association Cardiovascular Radiology, Atherosclerotic Peripheral Vascular Disease Working Group, Quality of Care Outcomes in Research Interdisciplinary Working Group, Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007 115 20 e478 534 2-s2.0-41249092747
4. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. New England Journal of Medicine 1995 333 24 1581 1587
5. Kwiatkowski T. G., Libman R. B., Frankel M., Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. New England Journal of Medicine 1999 340 23 1781 1787
6. Hacke W., Kaste M., Bluhmki E., Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. New England Journal of Medicine 2008 359 13 1317 1329
7. Lees K. R., Bluhmki E., von Kummer R., Brott T. G., Toni D., Grotta J. C., Albers G. W., Kaste M., Marler J. R., Hamilton S. A., Tilley B. C., Davis S. M., Donnan G. A., Hacke W., Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. The Lancet 2010 375 9727 1695 1703 2-s2.0-77952112006 10.1016/S0140-6736(10)60491-6
8. Blackham K. A., Meyers P. M., Abruzzo T. A., Endovascular therapy of acute ischemic stroke: report of the Standards of Practice Committee of the Society of NeuroInterventional Surgery. Journal of NeuroInterventional Surgery 2012 4 2 87 93
9. Smith W. S., Sung G., Saver J., Budzik R., Duckwiler G., Liebeskind D. S., Lutsep H. L., Rymer M. M., Higashida R. T., Starkman S., Gobin Y. P., Mechanical thrombectomy for acute ischemic stroke: final results of the multi MERCI trial. Stroke 2008 39 4 1205 1212 2-s2.0-41149121206 10.1161/STROKEAHA. 107.497115 (Pubitemid 351440692)
10. Darkhabani Z., Nguyen T., Lazzaro M. A., Complications of endovascular therapy for acute ischemic stroke and proposed management approach. Neurology 2012 79 13, supplement 1 S192 S198
11. Merino J. G., Warach S., Imaging of acute stroke. Nature Reviews Neurology 2010 6 10 560 571
12. Albers G. W., Thijs V. N., Wechsler L., Kemp S., Schlaug G., Skalabrin E., Bammer R., Kakuda W., Lansberg M. G., Shuaib A., Coplin W., Hamilton S., Moseley M., Marks M. P., Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Annals of Neurology 2006 60 5 508 517 2-s2.0-33845298309 10.1002/ana.20976 (Pubitemid 44871793)
13. Paciaroni M., Caso V., Agnelli G., The concept of ischemic penumbra in acute stroke and therapeutic opportunities. European Neurology 2009 61 6 321 330 2-s2.0-64149128201 10.1159/000210544
14. Heiss W. D., The ischemic penumbra: correlates in imaging and implications for treatment of ischemic stroke. The Johann Jacob Wepfer award 2011. Cerebrovascular Diseases 2011 32 4 307 320
15. Davis S. M., Donnan G. A., Parsons M. W., Levi C., Butcher K. S., Peeters A., Barber P. A., Bladin C., De Silva D. A., Byrnes G., Chalk J. B., Fink J. N., Kimber T. E., Schultz D., Hand P. J., Frayne J., Hankey G., Muir K., Gerraty R., Tress B. M., Desmond P. M., Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. The Lancet Neurology 2008 7 4 299 309 2-s2.0-40949161352 10.1016/S1474-4422(08)70044-9
16. Lin W. L., Powers W. J., Special issue: clinical imaging of hyperacute stroke. Translational Stroke Research 2012 3 2 173 177
17. Konstas A. A., Wintermark M., Lev M. H., CT perfusion imaging in acute stroke. Neuroimaging Clinics of North America 2011 21 2 215 238 2-s2.0-79957834472 10.1016/j.nic.2011.01.008
18. Fisher M., Bastan B., Identifying and utilizing the ischemic penumbra. Neurology 2012 79 13, supplement 1 S79 S85
19. Sobesky J., Refining the mismatch concept in acute stroke: lessons learned from PET and MRI. Journal of Cerebral Blood Flow & Metabolism 2012 32 7 1416 1425
20. Ebinger M., De Silva D. A., Christensen S., Parsons M. W., Markus R., Donnan G. A., Davis S. M., Imaging the penumbra-strategies to detect tissue at risk after ischemic stroke. Journal of Clinical Neuroscience 2009 16 2 178 187 2-s2.0-58149194564 10.1016/j.jocn.2008.04.002
21. Schlaug G., Benfield A., Baird A. E., Siewert B., Lövblad K. O., Parker R. A., Edelman R. R., Warach S., The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology 1999 53 7 1528 1537 2-s2.0-0032738040 (Pubitemid 29491949)
22. Engelter S. T., Wetzel S. G., Bonati L. H., Fluri F., Lyrer P. A., The clinical significance of diffusion-weighted MR imaging in stroke and TIA patients. Swiss Medical Weekly 2008 138 49-50 729 740 2-s2.0-58149231227
23. Dani K. A., Thomas R. G., Chappell F. M., Computed tomography and magnetic resonance perfusion imaging in ischemic stroke: definitions and thresholds. Annals of Neurology 2011 70 3 384 401
24. Powers W. J., Perfusion-diffusion mismatch: does it identify who will benefit from reperfusion therapy? Translational Stroke Research 2012 3 2 182 187
25. Allmendinger A. M., Tang E. R., Lui Y. W., Imaging of stroke: part 1, Perfusion CT-overview of imaging technique, interpretation pearls, and common pitfalls. American Journal of Roentgenology 2012 198 1 52 62 10.2214/AJR.10.7255
26. Bivard A., Levi C., Spratt N., Perfusion CT in acute stroke: a comprehensive analysis of infarct and penumbra. Radiology 2012 10.1148/radiol.12120971
27. Powers W. J., Zazulia A. R., PET in cerebrovascular disease. PET Clinics 2010 5 1 83106
28. Astrup J., Siejo B. K., Symon L., Thresholds in cerebral ischemia-the ischemic penumbra. Stroke 1981 12 6 723 725 2-s2.0-0019822988 (Pubitemid 12227362)
29. Baron J. C., Bousser M. G., Rey A., Reversal of focal "misery-perfusion syndrome" by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15O positron emission tomography. Stroke 1981 12 4 454 459 2-s2.0-0019425420 (Pubitemid 11046690)
30. Heiss W. D., Rosner G., Functional recovery of cortical neurons as related to degree and duration of ischemia. Annals of Neurology 1983 14 3 294 301 2-s2.0-0020573697 (Pubitemid 13051232)
31. Marcoux F. W., Morawetz R. B., Crowell R. M., Differential regional vulnerability in transient focal cerebral ischemia. Stroke 1982 13 3 339 346 2-s2.0-0020038768 (Pubitemid 12107356)
32. Heiss W. D., Graf R., Wienhard K., Lottgen J., Saito R., Fujita T., Rosner G., Wagner R., Dynamic penumbra demonstrated by sequential multitracer PET after middle cerebral artery occlusion in cats. Journal of Cerebral Blood Flow and Metabolism 1994 14 6 892 902 2-s2.0-0028138636 (Pubitemid 24332933)
33. Giffard C., Young A. R., Kerrouche N., Derlon J. M., Baron J. C., Outcome of acutely ischemic brain tissue in prolonged middle cerebral artery occlusion: a serial positron emission tomography investigation in the baboon. Journal of Cerebral Blood Flow and Metabolism 2004 24 5 495 508 2-s2.0-2342656894 (Pubitemid 38608281)
34. Pappata S., Fiorelli M., Rommel T., Hartmann A., Dettmers C., Yamaguchi T., Chabriat H., Poline J. B., Crouzel C., Di Giamberardino L., Baron J. C., PET study of changes in local brain hemodynamics and oxygen metabolism after unilateral middle cerebral artery occlusion in baboons. Journal of Cerebral Blood Flow and Metabolism 1993 13 3 416 424 2-s2.0-0027245912 (Pubitemid 23129395)
35. Touzani O., Young A. R., Derlon J. M., Beaudouin V., Marchal G., Rioux P., Mezenge F., Baron J. C., MacKenzie E. T., Traystman R. J., Sequential studies of severely hypometabolic tissue volumes after permanent middle cerebral artery occlusion: a positron emission tomographic investigation in anesthetized baboons. Stroke 1995 26 11 2112 2119 2-s2.0-0028792448
36. Shimosegawa E., Hatazawa J., Ibaraki M., Toyoshima H., Suzuki A., Metabolic penumbra of acute brain infarction: a correlation with infarct growth. Annals of Neurology 2005 57 4 495 504 2-s2.0-16344368832 10.1002/ana.20427 (Pubitemid 40471158)
37. Furlan M., Marchai G., Viader F., Derlon J. M., Baron J. C., Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Annals of Neurology 1996 40 2 216 226 2-s2.0-0029814808 (Pubitemid 26274557)
38. Frykholm P., Andersson J. L. R., Valtysson J., Silander H. C., Hillered L., Persson L., Olsson Y., Yu W. R., Westerberg G., Watanabe Y., Långström B., Enblad P., A metabolic threshold of irreversible ischemia demonstrated by PET in a middle cerebral artery occlusion-reperfusion primate model. Acta Neurologica Scandinavica 2000 102 1 18 26 2-s2.0-0034087002 10.1034/j.1600-0404.2000.102001018.x (Pubitemid 30416943)
39. Sakoh M., Østergaard L., Røhl L., Smith D. F., Simonsen C. Z., Sørensen J. C., Poulsen P. V., Gyldensted C., Sakaki S., Gjedde A., Relationship between residual cerebral blood flow and oxygen metabolism as predictive of ischemic tissue viability: sequential multitracer positron emission tomography scanning of middle cerebral artery occlusion during the critical first 6 hours after stroke in pigs. Journal of Neurosurgery 2000 93 4 647 657 2-s2.0-0034433687 (Pubitemid 32799300)
40. Heiss W. D., Huber M., Fink G. R., Herholz K., Pietrzyk U., Wagner R., Wienhard K., Progressive derangement of periinfarct viable tissue in ischemic stroke. Journal of Cerebral Blood Flow and Metabolism 1992 12 2 193 203 2-s2.0-0026531605
41. Tillisch J., Brunken R., Marshall R., Reversibility of cardial wall-motion abnormalities predicted by positron tomography. New England Journal of Medicine 1986 314 14 884 888 2-s2.0-0022559948 (Pubitemid 16126116)
42. Tamaki N., Kawamoto M., Tadamura E., Magata Y., Yonekura Y., Nohara R., Sasayama S., Nishimura K., Ban T., Konishi J., Prediction of reversible ischemia after revascularization: perfusion and metabolic studies with positron emission tomography. Circulation 1995 91 6 1697 1705 2-s2.0-0028910959
43. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis. Ontario Health Technology Assessment Series 2010 10 16 1 80
44. Garibotto V., Heinzer S., Vulliemoz S., Clinical applications of hybrid PET/MRI in neuroimaging. Clinical Nuclear Medicine 2013 38 1 e13 e18
45. Baron J. C., Rougemont D., Soussaline F., Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients: a positron tomography study. Journal of Cerebral Blood Flow and Metabolism 1984 4 2 140 149 2-s2.0-0021196138 (Pubitemid 14080142)
46. Lebrun Grandie P., Baron J. C., Soussaline F., Coupling between regional blood flow and oxygen utilization in the normal human brain. A study with positron tomography and oxygen 15. Archives of Neurology 1983 40 4 230 236 2-s2.0-0020658255 (Pubitemid 13161434)
47. Vannucci S. J., Maher F., Simpson I. A., Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 1997 21 1 2 21 (Pubitemid 27389636)
48. Wilson J. E., Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. Journal of Experimental Biology 2003 206 12 2049 2057 2-s2.0-0038714272 10.1242/jeb.00241 (Pubitemid 36761808)
49. Ginsberg M. D., Reivich M., Giandomenico A., Greenberg J. H., Local glucose utilization in acute focal cerebral ischemia: local dysmetabolism and diaschisis. Neurology 1977 27 11 1042 1048 2-s2.0-0017747510 (Pubitemid 8230801)
50. Paschen W., Mies G., Hossmann K. A., Threshold relationship between cerebral blood flow, glucose utilization, and energy metabolites during development of stroke in gerbils. Experimental Neurology 1992 117 3 325 333 2-s2.0-0026785912 10.1016/0014-4886(92)90142-D
51. 18FDG. Seminars in Nuclear Medicine 2002 32 1 6 12 2-s2.0-0036151721 (Pubitemid 34112939)
52. Schulthess G. K. V., Molecular Anatomic Imaging: PET-CT and SPECT-CT Integrated Modality 2007 2nd Philadelphia, Pa, USA Lippincott Williams & Wilkins
53. Cook G. J. R., Maisey M. N., Fogelman I., Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine. European Journal of Nuclear Medicine 1999 26 10 1363 1378 2-s2.0-0032885033 10.1007/s002590050597 (Pubitemid 29467035)
54. Walberer M., Backes H., Rueger M. A., Potential of early [(18)F]-2-fluoro-2-deoxy-D-glucose positron emission tomography for identifying hypoperfusion and predicting fate of tissue in a rat embolic stroke model. Stroke 2012 43 1 193 198
55. 18F-FDG PET and MRI techniques in permanent and transient focal cerebral ischemia in rats. NeuroImage 2011 57 1 45 54 2-s2.0-79956214631 10.1016/j.neuroimage.2011.04.045
56. Kuge Y., Yokota C., Tagaya M., Hasegawa Y., Nishimura A., Kito G., Tamaki N., Hashimoto N., Yamaguchi T., Minematsu K., Serial changes in cerebral blood flow and flow-metabolism uncoupling in primates with acute thromboembolic stroke. Journal of Cerebral Blood Flow and Metabolism 2001 21 3 202 210 2-s2.0-0035092908 (Pubitemid 32207419)
57. Kuge Y., Hasegawa Y., Yokota C., Minematsu K., Hashimoto N., Miyake Y., Yamaguchi T., Effects of single and repetitive spreading depression on cerebral blood flow and glucose metabolism in cats: a PET study. Journal of the Neurological Sciences 2000 176 2 114 123 2-s2.0-0034659144 10.1016/S0022- 510X(00)00327-0 (Pubitemid 30621608)
58. Fukumoto D., Hosoya T., Nishiyama S., Harada N., Iwata H., Yamamoto S., Tsukada H., Multiparametric assessment of acute and subacute ischemic neuronal damage: a small animal positron emission tomography study with rat photochemically induced thrombosis model. Synapse 2011 65 3 207 214 2-s2.0-78650641650 10.1002/syn.20836
59. 11C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats. Journal of Cerebral Blood Flow and Metabolism 2007 27 12 1975 1986 2-s2.0-36249006825 10.1038/sj.jcbfm.9600500 (Pubitemid 350129165)
60. 18F-FDG PET in acute ischemic stroke: assessment of hyper accumulation around the lesion. Kaku Igaku 2002 39 2 103 110 2-s2.0-0036015249 (Pubitemid 34601354)
61. 3 Annals of Neurology 1980 8 1 47 60 2-s2.0-0018823545 (Pubitemid 10056350)
62. Ho D. Y., Mocarski E. S., Sapolsky R. M., Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene. Proceedings of the National Academy of Sciences of the United States of America 1993 90 8 3655 3659 2-s2.0-0027416053 (Pubitemid 23111426)
63. Yenari M. A., Dumas T. C., Sapolsky R. M., Steinberg G. K., Gene therapy for treatment of cerebral ischemia using defective herpes simplex viral vectors. Annals of the New York Academy of Sciences 2001 939 340 357 2-s2.0-0034942540 (Pubitemid 32620085)
64. Lawrence M. S., Sun G. H., Kunis D. M., Saydam T. C., Dash R., Ho D. Y., Sapolsky R. M., Steinberg G. K., Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke. Journal of Cerebral Blood Flow and Metabolism 1996 16 2 181 185 2-s2.0-9044254927 (Pubitemid 26062808)
65. Lee W. H., Bondy C. A., Ischemic injury induces brain glucose transporter gene expression. Endocrinology 1993 133 6 2540 2544 2-s2.0-0027138084 10.1210/en.133.6.2540 (Pubitemid 24000700)
66. McCall A. L., Van Bueren A. M., Nipper V., Moholt-Siebert M., Downes H., Lessov N., Forebrain ischemia increases GLUT1 protein in brain microvessels and parenchyma. Journal of Cerebral Blood Flow and Metabolism 1996 16 1 69 76 2-s2.0-0030034118
67. Vannucci S. J., Seaman L. B., Vannucci R. C., Effects of hypoxia-ischemia on GLUT1 and GLUT3 glucose transporters in immature rat brain. Journal of Cerebral Blood Flow and Metabolism 1996 16 1 77 81 2-s2.0-0030051010 (Pubitemid 26007952)
68. Li K., Vannucci S. J., Maher F., GLUT5 microglial response in adult and immature rat brain following stroke. Society For Neuroscience Abstracts 1996 22 1-3 1423
69. Greijer A. E., van der Groep P., Kemming D., Shvarts A., Semenza G. L., Meijer G. A., van de Wiel M. A., Belien J. A. M., van Diest P. J., van der Wall E., Up-regualtion of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor I (HIF-I). Journal of Pathology 2005 206 3 291 304 2-s2.0-21344438419 10.1002/path.1778 (Pubitemid 40903193)
70. 18FDG lumped constant and cardiac protection. Journal of Bioenergetics and Biomembranes 2009 41 2 187 193 2-s2.0-67650665535 10.1007/s10863-009-9207-9
71. Clanton T. L., Klawitter P. F., Physiological and genomic consequences of intermittent hypoxia: invited review: adaptive responses of skeletal muscle to intermittent hypoxia: the known and the unknown. Journal of Applied Physiology 2001 90 6 2476 2487 2-s2.0-0034996967 (Pubitemid 32471862)
72. Malthankar-Phatak G. H., Patel A. B., Xia Y., Hong S., Chowdhury G. M. I., Behar K. L., Orina I. A., Lai J. C. K., Effects of continuous hypoxia on energy metabolism in cultured cerebro-cortical neurons. Brain Research 2008 1229 1 147 154 2-s2.0-50049102678 10.1016/j.brainres.2008.06.074
73. Vannucci R. C., Brucklacher R. M., Vannucci S. J., Glycolysis and perinatal hypoxic-ischemic brain damage. Developmental Neuroscience 2005 27 2-4 185 190 2-s2.0-23244434255 10.1159/000085991 (Pubitemid 41096225)
74. Weinstein J. R., Koerner I. P., Moller T., Microglia in ischemic brain injury. Future Neurology 2010 5 2 227 246
75. Lambertsen K. L., Biber K., Finsen B., Inflammatory cytokines in experimental and human stroke. Journal of Cerebral Blood Flow & Metabolism 2012 32 9 1677 1698
76. Yamada S., Kubota K., Kubota R., Ido T., Tamahashi N., High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. Journal of Nuclear Medicine 1995 36 7 1301 1306 2-s2.0-0029071943
77. Sugawara Y., Gutowski T. D., Fisher S. J., Brown R. S., Wahl R. L., Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, L-methionine, 67Ga-citrate, and 125I-HSA. European Journal of Nuclear Medicine 1999 26 4 333 341 2-s2.0-0032890759 10.1007/s002590050395 (Pubitemid 29176443)
78. 18F-FDG uptake in experimental soft-tissue abscesses in rats. Radiology 2002 223 2 446 451 2-s2.0-0036011171 (Pubitemid 34454324)
79. Kubota K., Ito K., Morooka M., Minamimoto R., Miyata Y., Yamashita H., Takahashi Y., Mimori A., FDG PET for rheumatoid arthritis: basic considerations and whole-body PET/CT. Annals of the New York Academy of Sciences 2011 1228 1 29 38 2-s2.0-79959805079 10.1111/j.1749-6632.2011.06031.x
80. Yamashita K., Vogel P., Fritze K., Back T., Hossmann K. A., Wiessner C., Monitoring the temporal and spatial activation pattern of astrocytes in focal cerebral ischemia using in situ hybridization of GFAP mRNA: comparison with sgp-2 and hsp70 mRNA and the effect of glutamate receptor antagonists. Brain Research 1996 735 2 285 297 2-s2.0-0030574090 10.1016/0006-8993(96)00578-1 (Pubitemid 26345940)
81. Mabuchi T., Kitagawa K., Ohtsuki T., Kuwabara K., Yagita Y., Yanagihara T., Hori M., Matsumoto M., Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke 2000 31 7 1735 1743 2-s2.0-0033933546 (Pubitemid 30437531)
82. 18F]FDG-PET study. Journal of Cerebral Blood Flow and Metabolism 2009 29 6 1216 1225 2-s2.0-67349283094 10.1038/jcbfm.2009.36
83. Chuaqui R., Tapia J., Histologic assessment of the age of recent brain infarcts in man. Journal of Neuropathology and Experimental Neurology 1993 52 5 481 489 2-s2.0-0027213868 (Pubitemid 23269196)
84. Lindsberg P. J., Carpén O., Paetau A., Karjalainen-Lindsberg M. L., Kaste M., Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation 1996 94 5 939 945 2-s2.0-0029808409 (Pubitemid 26292844)
85. Pozzilli C., Lenzi G. L., Argentino C., Imaging of leukocytic infiltration in human cerebral infarcts. Stroke 1985 16 2 251 255 2-s2.0-0021954360 (Pubitemid 15144729)
86. Akopov S. E., Simonian N. A., Grigorian G. S., Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. Stroke 1996 27 10 1739 1743 2-s2.0-0029780302 (Pubitemid 26332496)
87. 11C](R)- PK11195 PET study. NeuroImage 2005 24 2 591 595 2-s2.0-16244422002 10.1016/j.neuroimage.2004.09.034 (Pubitemid 41359057)
88. Price C. J. S., Wang D., Menon D. K., Guadagno J. V., Cleij M., Fryer T., Aigbirhio F., Baron J. C., Warburton E. A., Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke. Stroke 2006 37 7 1749 1753 2-s2.0-33745942789 10.1161/01.STR.0000226980.95389.0b (Pubitemid 44297724)
89. Syapin P. J., Skolnick P., Characterization of benzodiazepine binding sites in cultured cells of neural origin. Journal of Neurochemistry 1979 32 3 1047 1051 2-s2.0-0018347895 (Pubitemid 9133265)
90. Canat X., Carayon P., Bouaboula M., Cahard D., Shire D., Roque C., Le Fur G., Casellas P., Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells. Life Sciences 1993 52 1 107 118 2-s2.0-0027326878 10.1016/0024-3205(93)90293-C (Pubitemid 223039988)
91. Hossmann K. A., Periinfarct depolarizations. Cerebrovascular and Brain Metabolism Reviews 1996 8 3 195 208
92. Lauritzen M., Dreier J. P., Fabricius M., Hartings J. A., Graf R., Strong A. J., Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. Journal of Cerebral Blood Flow and Metabolism 2011 31 1 17 35 2-s2.0-78650895470 10.1038/jcbfm.2010.191
93. Somjen G. G., Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiological Reviews 2001 81 3 1065 1096 2-s2.0-0034953204 (Pubitemid 32606666)
94. Mies G., Iijima T., Hossmann K. A., Correlation between peri-infarct DC shifts and ischaemic neuronal damage in rat. NeuroReport 1993 4 6 709 711 2-s2.0-0027246395 (Pubitemid 23190898)
95. Ohta K., Graf R., Rosner G., Heiss W. D., Calcium ion transients in peri-infarct depolarizations may deteriorate ion homeostasis and expand infarction in focal cerebral ischemia in cats. Stroke 2001 32 2 535 543 2-s2.0-0035135596 (Pubitemid 32155248)
96. Dohmen C., Sakowitz O. W., Fabricius M., Spreading depolarizations occur in human ischemic stroke with high incidence. Annals of Neurology 2008 63 6 720 728 (Pubitemid 351945531)
97. Fabricius M., Fuhr S., Bhatia R., Boutelle M., Hashemi P., Strong A. J., Lauritzen M., Cortical spreading depression and peri-infarct depolarization in acutely injured human cerebral cortex. Brain 2006 129 3 778 790 2-s2.0-33244462144 10.1093/brain/awh716 (Pubitemid 43278239)
98. Fujita H., Zhang B., Sato K., Tanaka J., Sakanaka M., Expressions of neuropilin-1, neuropilin-2 and semaphorin 3A mRNA in the rat brain after middle cerebral artery occlusion. Brain Research 2001 914 1-2 1 14 2-s2.0-0035964880 10.1016/S0006-8993(01)02765-2 (Pubitemid 32905426)
99. Barde Y. A., Neurotrophins: a family of proteins supporting the survival of neurons. Progress in Clinical and Biological Research 1994 390 45 56
100. A receptors in the cortical penumbra. Molecular Brain Research 2003 111 1-2 24 30 2-s2.0-0347033247 10.1016/S0169-328X(02)00666-6 (Pubitemid 36332326)
101. Ferrer I., Krupinski J., Goutan E., Martí E., Ambrosio S., Arenas E., Brain-derived neurotrophic factor reduces cortical cell death by ischemia after middle cerebral artery occlusion in the rat. Acta Neuropathologica 2001 101 3 229 238 2-s2.0-0035109207 (Pubitemid 32219756)
102. Phelps M. E., Positron computed tomography studies of cerebral glucose metabolism in man: theory and application in nuclear medicine. Seminars in Nuclear Medicine 1981 11 1 32 49 2-s2.0-0019399607
103. Nakai H., Yamamoto Y. L., Diksic M., Worsley K. J., Takara E., Triple-tracer autoradiography demonstrates effects of hyperglycemia on cerebral blood flow, pH, and glucose utilization in cerebral ischemia of rats. Stroke 1988 19 6 764 772 2-s2.0-0023944657
104. Noll T., Mühlensiepen H., Engels R., Hamacher K., Papaspyrou M., Langen K. J., Biselli M., A cell-culture reactor for the on-line evaluation of radiopharmaceuticals: evaluation of the lumped constant of FDG in human glioma cells. Journal of Nuclear Medicine 2000 41 3 556 564 2-s2.0-0343819886 (Pubitemid 30133978)
105. Nakai H., Matsuda H., Takara E., Simultaneous in vivo measurement of lumped constant and rate constants in experimental cerebral ischemia using F-18 FDG. Stroke 1987 18 1 158 167 2-s2.0-0023099861 (Pubitemid 17016702)
106. 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. Journal of Nuclear Medicine 2006 47 6 1059 1066 2-s2.0-33746036112 (Pubitemid 46939960)
107. 18F]FDG, version 2. European Journal of Nuclear Medicine and Molecular Imaging 2009 36 12 2103 2110 2-s2.0-71849110016 10.1007/s00259-009-1264-0
108. Videen T. O., Dunford-Shore J. E., Diringer M. N., Powers W. J., Correction for partial volume effects in regional blood flow measurements adjacent to hematomas in humans with intracerebral hemorrhage: implementation and validation. Journal of Computer Assisted Tomography 1999 23 2 248 256 2-s2.0-0033064956 10.1097/00004728-199903000-00014 (Pubitemid 29138502)
109. Melamed E., Reactive hyperglycaemia in patients with acute stroke. Journal of the Neurological Sciences 1976 29 2-4 267 275
110. Thie J. A., Smith G. T., Hubner K. F., 2-deoxy-2-[F-18]fluoro-D-glucose- positron emission tomography sensitivity to serum glucose: a survey and diagnostic applications. Molecular Imaging and Biology 2005 7 5 361 368 2-s2.0-33644883045 10.1007/s11307-005-0018-z (Pubitemid 44193413)
111. Florence G., Guerit J. M., Gueguen B., Electroencephalography (EEG) and somatosensory evoked potentials (SEP) to prevent cerebral ischaemia in the operating room. Neurophysiologie Clinique 2004 34 1 17 32 2-s2.0-1642337142 10.1016/j.neucli.2004.01.001 (Pubitemid 38367892)
112. Haupt W. F., Horsch S., Evoked potential monitoring in carotid surgery: a review of 994 cases. Neurology 1992 42 4 835 838 2-s2.0-0026609577